恒星科技(002132.SZ):擬斥資5000萬元-6000萬元回購公司股份
格隆匯6月11日丨恒星科技(002132.SZ)公佈,擬回購公司發行的A股社會公眾股,用於維護公司價值及股東權益所必需,回購的股份後續將用於出售,出售將按照相關規則要求進行。擬回購金額不低於人民幣5,000萬元(含),不超過人民幣6,000萬元(含)。回購股份價格不超過人民幣3.76元/股(含)。按照回購資金總額的上下限及回購價格上限3.76元/股計算,預計回購股份數量約為13,297,872股至15,957,446股,約佔公司目前總股本的0.95%至1.14%,具體以回購期滿時實際回購的股份數量為準。回購期限自董事會審議通過回購股份方案後3個月內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.